Robuta

Sponsor of the Day: Jerkmate
https://www.medrxiv.org/content/10.1101/2020.04.16.20067835v1 Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs |... Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing COVID-19 pandemic. The current gold standard for COVID-19 diagnosis... sars cov 2covid 19 patientssalivasensitivedetection https://www.engadget.com/mit-csail-coronavirus-patient-monitoring-device-190037775.html MIT uses wireless signals and AI to monitor COVID-19 patients at home Apr 14, 2020 - A team from MIT's CSAIL developed a wireless device that uses AI to monitor COVID-19 patients in their homes. covid 19 patientswireless signalsmitusesai https://www.cureus.com/articles/179159-doxycycline-vs-hydroxychloroquine--azithromycin-in-the-management-of-covid-19-patients-an-open-label-randomized-clinical-trial-in-sub-saharan-africa-doxycov Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An... Objective We aimed to compare the safety and efficacy of a doxycycline-based regimen against Cameroon National Standard Guidelines (hydroxychloroquine plus... covid 19 patientsdoxycyclinevshydroxychloroquineazithromycin https://www.panafrican-med-journal.com/content/series/37/1/9/full/ Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients... INTRODUCTION: COVID-19 is a global pandemic seen in modern times. The clinical characteristics, treatment regimen and duration of hospitalization of COVID-19... covid 19 patientsclinical characteristicstreatmentregimenduration https://www.medrxiv.org/content/10.1101/2020.05.12.20099028v1 Outcomes of Hydroxychloroquine Treatment Among Hospitalized COVID-19 Patients in the United States-... On March 28, 2020, in response to the rapidly accelerating COVID-19 pandemic, U.S FDA issued emergency use authorization for hydroxychloroquine (HCQ) in... among hospitalized covid19 patientsunited statesoutcomeshydroxychloroquine https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0244272 Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital... Objectives To describe the clinical characteristics of patients infected with SARS-CoV-2 at Clinique Ngaliema, a public hospital, in Kinshasa, in the... covid 19 patientsclinical characteristicspublic hospitalhospitalizedclinique https://link.springer.com/article/10.1007/s11739-021-02742-8?error=cookies_not_supported&code=f4e17665-438e-412e-9554-7ccd1804d886 Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards... Apr 24, 2021 - During the COVID-19 2020 outbreak, a large body of data has been provided on general management and outcomes of hospitalized COVID-19 patients. Yet, relati covid 19 patientsclinical factorsinternal medicineassociateddeath https://www.jstage.jst.go.jp/article/tjem/252/1/252_73/_article Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals. mortality risk factorsamong hospitalized covid19 patientsreferral centermajor https://www.medrxiv.org/content/10.1101/2021.03.08.21252883v1 Outcome of Different Therapeutic Interventions in Mild COVID-19 Patients in a Single OPD Clinic of... Introduction With over 87,273,380 cases being reported and 1,899,440 deaths worldwide as of 9th January 2021, Coronavirus disease 2019 (COVID-19) has become... mild covid 19different therapeuticoutcomeinterventionspatients https://www.factcheck.org/2022/09/scicheck-clinical-trials-show-ivermectin-does-not-benefit-covid-19-patients-contrary-to-social-media-claims/ Clinical Trials Show Ivermectin Does Not Benefit COVID-19 Patients, Contrary to Social Media Claims... Jun 3, 2024 - Randomized clinical trials have repeatedly found that ivermectin does not benefit COVID-19 patients. The National Institutes of Health recommends against its... covid 19 patientsclinical trialssocial mediashowivermectin https://www.medrxiv.org/content/10.1101/2021.07.06.21259924v1 Effectiveness of Ivermectin-Based Multidrug Therapy in Severe Hypoxic Ambulatory COVID-19 Patients... Ivermectin is a safe, inexpensive and effective early COVID-19 treatment validated in 20+ RCTs. Having developed combination therapies for Helicobacter pylori... covid 19 patientseffectivenessivermectinbasedmultidrug https://link.springer.com/article/10.1007/s11739-020-02505-x?error=cookies_not_supported&code=ff806a37-8ea3-40fa-8e24-87f6235418dc The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients |... Sep 30, 2020 - This study investigates the association between the treatment with hydroxychloroquine and mortality in patients admitted with COVID-19. Routinely recorded, covid 19 patientshospital mortalityassociationtreatmenthydroxychloroquine https://www.medrxiv.org/content/10.1101/2020.09.09.20184143v1 The Effect of Early Hydroxychloroquine-based Therapy in COVID-19 Patients in Ambulatory Care... BACKGROUND Currently, there is no proven effective therapy nor vaccine for the treatment of SARS-CoV-2. Evidence regarding the potential benefit of early... covid 19 patientsbased therapyambulatory careeffectearly https://link.springer.com/article/10.1007/s11427-020-1782-1?error=cookies_not_supported&code=d3bff5b3-ec2f-4006-bbef-9c740dac760c Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting... covid 19 patientsbeneficial effectsexertedhydroxychloroquinetreating https://www.medrxiv.org/content/10.1101/2021.03.08.21252883v2 Outcome of Different Therapeutic Interventions in Mild COVID-19 Patients in a Single OPD Clinic of... Introduction With over 87,273,380 cases being reported and 1,899,440 deaths worldwide as of 9th January 2021, Coronavirus disease 2019 (COVID-19) has become... mild covid 19different therapeuticoutcomeinterventionspatients https://www.center4research.org/nchr-long-covid-teleconferences-national-conference-project/ Improving Outcomes for Long COVID-19 Patients - National Center for Health Research Feb 7, 2023 - The project “Engaging Stakeholders in Patient-Centered Outcomes Research and Clinical Effectiveness Research to Improve Outcomes for Post-Acute COVID-19... long covid 19national center healthimproving outcomespatientsresearch https://c19early.org/efimenko.html Efimenko: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients:... covid 19 patientstreatmentivermectinassociateddecreased https://www.cureus.com/articles/122896-predictive-factors-of-death-and-the-clinical-profile-of-hospitalized-covid-19-patients-in-morocco-a-one-year-mixed-cohort-study Predictive Factors of Death and the Clinical Profile of Hospitalized Covid-19 Patients in Morocco:... Background Since the onset of the Covid-19 pandemic, several studies have been conducted around the world in an attempt to understand this heterogeneous and... hospitalized covid 19clinical profilepredictivefactorsdeath https://ufhealth.org/news/2021/two-drug-combo-shows-dramatic-results-covid-19-patients-uf-health-researchers-find Two-drug combo shows dramatic results for COVID-19 patients, UF Health researchers find - UF Health Combining an anti-inflammatory drug with an antiviral drug reduces recovery time and accelerates improvement for COVID-19 patients, a national study… covid 19 patientstwo drugshows dramaticuf healthresearchers find https://www.cbsnews.com/baltimore/news/8-year-old-columbia-girl-uses-birthday-to-raise-money-for-covid-19-patients/ 8-Year-Old Columbia Girl Uses Birthday To Raise Money For COVID-19 Patients - CBS Baltimore Aug 29, 2020 - Ada Cottrell celebrated her 8th birthday by raising money for people during the coronavirus pandemic. 8 year oldcovid 19 patientsgirl usesraise moneycbs baltimore https://www.cureus.com/articles/263779-anticoagulant-use-in-covid-19-patients-a-longitudinal-study-from-zanjan-iran Anticoagulant Use in COVID-19 Patients: A Longitudinal Study From Zanjan, Iran | Cureus Background The mortality and morbidity of thrombotic events in patients with coronavirus disease 2019 (COVID-19) are increasing worldwide. The clinical impact... covid 19 patientslongitudinal studyanticoagulantuseiran https://www.medrxiv.org/content/10.1101/2021.03.04.21252084v1 Factors associated with increased mortality in critically ill COVID-19 patients in a Mexican public... BACKGROUND The lethality rate of COVID-19 in Mexico is one of the highest worldwide, but in-hospital factors associated with this increased rate have yet to be... covid 19 patientsfactors associatedcritically illincreasedmortality https://www.pjms.org.pk/index.php/pjms/article/view/8757 Effectiveness of early pharmaceutical interventions in symptomatic COVID-19 patients: A randomized... covid 19 patientseffectivenessearlypharmaceuticalinterventions https://link.springer.com/article/10.1007/s11739-021-02742-8?error=cookies_not_supported&code=437d4d58-30a1-4150-a19e-a235e1ed7711 Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards... Apr 24, 2021 - During the COVID-19 2020 outbreak, a large body of data has been provided on general management and outcomes of hospitalized COVID-19 patients. Yet, relati covid 19 patientsclinical factorsinternal medicineassociateddeath https://www.jstage.jst.go.jp/article/tjem/252/1/252_73/_article/-char/ja/ Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran mortality risk factorsamong hospitalized covid19 patientsreferral centermajor https://www.factcheck.org/2021/08/scicheck-hospitals-overwhelmed-by-another-surge-of-covid-19-patients-financial-strain/ Hospitals Overwhelmed by Another Surge of COVID-19 Patients, Financial Strain - FactCheck.org Aug 24, 2021 - The seven-day average of COVID-19 hospitalizations in the U.S. has increased by 322% in two months, straining the ability of medical staff in some states to... covid 19 patientsfinancial strainhospitalsoverwhelmedanother https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242184 Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients | PLOS One Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin... severe covid 19plos onelackefficacystandard https://www.news-medical.net/news/20260424/COVID-19-patients-with-STEMI-show-higher-one-year-mortality-rates.aspx COVID-19 patients with STEMI show higher one-year mortality rates Findings from the North American COVID-19 Myocardial Infarction (NACMI) registry demonstrate significantly higher one-year mortality rates in patients with... covid 19 patientsone year mortalityshow higherstemirates https://www.medrxiv.org/content/10.1101/2021.03.04.21252084v1.supplementary-material Factors associated with increased mortality in critically ill COVID-19 patients in a Mexican public... BACKGROUND The lethality rate of COVID-19 in Mexico is one of the highest worldwide, but in-hospital factors associated with this increased rate have yet to be... covid 19 patientsfactors associatedcritically illincreasedmortality https://c19early.org/charif.html Charif: Predictive Factors of Death and the Clinical Profile of Hospitalized Covid-19 Patients in... Charif, 615 patient HCQ late treatment study: 27% lower mortality (p=0.0005). Retrospective 615 hospitalized COVID-19 patients in Morocco, showing lower.. -... hospitalized covid 19clinical profilecharifpredictivefactors https://www.belgiqueenbonnesante.be/fr/donnees-phares-dans-les-soins-de-sante/covid-19-fr/activite-de-soins/chiffres-epidemiologiques/covid-19-patients-dans-les-hopitaux-generaux COVID-19 patients dans les hôpitaux généraux - Vers une Belgique en bonne santé Jan 30, 2023 - Vers une Belgique en bonne santé: indicateurs de santé et de soins covid 19 patientsvers une belgiquedans lesbonne https://www.medrxiv.org/content/10.1101/2023.07.13.23292643v1 Clinical manifestations and mortality among hospitalized COVID-19 patients in Tanzania, 2021-2022 |... among hospitalized covidclinical manifestations19 patients2021 2022mortality https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0238281 Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia,... This is a population-based prospective cohort study on archive data describing the age- and sex-specific prevalence of COVID-19 and its prognostic factors. All... covid 19 patientsreggio emiliacharacteristicsoutcomescohort https://www.medrxiv.org/content/10.1101/2020.12.11.20247437v1 Clinical and Demographic Characteristics of COVID-19 Patients Admitted in a Tertiary Care Hospital... To present clinical and demographic characteristics of COVID-19 patients admitted to Hospital Metropolitano de Santiago in Dominican Republic, we analyzed... covid 19 patientstertiary care hospitaldemographic characteristicsclinicaladmitted https://www.nature.com/articles/s41419-020-2721-8?error=cookies_not_supported&code=516037a2-dc69-479f-add6-e2b062193c42 Is hydroxychloroquine beneficial for COVID-19 patients? | Cell Death & Disease Jul 8, 2020 - The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019.... covid 19 patientscell deathhydroxychloroquinebeneficialdisease https://c19early.org/tehrani.html Tehrani: Risk factors for mortality in adult COVID-19 patients: frailty predicts fatal outcome in... Tehrani, 255 patient HCQ late treatment study: 13% lower mortality (p=0.63). Retrospective 255 hospitalized patients, 65 treated with HCQ, showing unadjusted..... covid 19 patientsrisk factorstehranimortalityadult https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0244272 Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital... Objectives To describe the clinical characteristics of patients infected with SARS-CoV-2 at Clinique Ngaliema, a public hospital, in Kinshasa, in the... covid 19 patientsclinical characteristicspublic hospitalhospitalizedclinique https://link.springer.com/article/10.1007/s11427-020-1782-1?error=cookies_not_supported&code=5e505e8d-ce46-4ceb-b130-2915e5b8cb8f Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting... covid 19 patientsbeneficial effectsexertedhydroxychloroquinetreating https://www.medrxiv.org/content/10.1101/2020.08.05.20151027v1 Time to negative PCR from symptom onset in COVID-19 patients on Hydroxychloroquine and Azithromycin... Background The role of hydroxychloroquine (HCQ) and azithromycin in the treatment of COVID-19 and its effect on SARS-CoV-2 viral clearance is not known.... covid 19 patientstimenegativepcrsymptom https://www.ijsciences.com/pub/article/2378 Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients sars cov 2covid 19 patientseffectivenessivermectin https://advances.massgeneral.org/cardiovascular/article.aspx?id=1179 ECMO as a Rescue Therapy for COVID-19 Patients - Mass General Advances in Motion Massachusetts General Hospital physicians have successfully used extracorporeal membrane oxygenation (ECMO) therapy as a bridge to recovery for critically ill... covid 19 patientsmass general advancesecmorescuetherapy https://link.springer.com/article/10.1007/s10067-020-05334-7?error=cookies_not_supported&code=9df32bc0-1394-48a5-a1e6-d21c94fdaad9 COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series |... Aug 27, 2020 - Covid-19 infection poses a serious challenge for immune-compromised patients with inflammatory autoimmune systemic diseases. We investigated the clinical-e covid 19systemic diseaseslarge italianrheumaticautoimmune https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0264789 Mortality and associated risk factors in patients hospitalized due to COVID-19 in a Peruvian... associated riskpatients hospitalizedcovid 19mortalityfactors https://www.abcimaging.org/article/cardiovascular-complications-in-patients-with-covid-19-and-their-relationship-with-mortality-an-echocardiographic-perspective/ Cardiovascular Complications in Patients with COVID-19 and Their Relationship with Mortality: An... Apr 1, 2026 - Abstract Background: Echocardiography plays a fundamental role in the diagnosis of cardiovascular diseases related to SARS-CoV-2 infection. Despite prior covid 19cardiovascularcomplicationspatientsrelationship https://www.mdanderson.org/cancerwise/leukemia-oncologist-doctor-reflections-on-caring-for-cancer-patients-during-the-coronavirus-covid-19-pandemic.h00-159381156.html Caring for leukemia patients during COVID-19: an oncologist’s reflections | UT MD Anderson Apr 21, 2020 - What is it like to round on MD Anderson’s inpatient leukemia unit during the coronavirus (COVID-19) pandemic? Naveen Pemmaraju, M.D., shares his observations... ut md andersoncovid 19caringleukemiapatients https://link.springer.com/article/10.1007/s00134-021-06448-5?error=cookies_not_supported&code=4ea86434-5025-4dec-aa6e-388c3b80f55f Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP... Jul 12, 2021 - To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adu critically ill patientslopinavir ritonavircovid 19hydroxychloroquineremap https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0264789 Mortality and associated risk factors in patients hospitalized due to COVID-19 in a Peruvian... associated riskpatients hospitalizedcovid 19mortalityfactors https://acutecaretesting.org/en/journal-scans/asymptomatic-severe-hypoxemia-reduced-po2 Asymptomatic severe hypoxemia is an important feature of COVID-19 for some patients; mechanisms... Asymptomatic severe hypoxemia (reduced pO2(a)) is an important feature of COVID-19 for some patients; mechanisms discussed and prognosis examined important featurecovid 19asymptomaticseverepatients https://c19early.org/roig.html Roig: Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients [HCQ] Roig, 79 patient HCQ late treatment study: 16% lower mortality (p=0.76). Retrospective 79 hospitalized nonagenarian patients showing unadjusted HCQ mortality..... covid 19roigclinicalpharmacologicaldata https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0252388 Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19... Background Hydroxychloroquine combined with azithromycin (HCQ/AZI) has initially been used against coronavirus disease-2019 (COVID-19). In this retrospective... efficacy hydroxychloroquinepatients hospitalizedcovid 19lackazithromycin https://www.nationalacademies.org/news/strategies-to-allocate-scarce-covid-19-monoclonal-antibody-treatments-to-eligible-patients-examined-in-new-rapid-response-to-government Strategies to Allocate Scarce COVID-19 Monoclonal Antibody Treatments to Eligible Patients Examined... Despite a scarce supply, a substantial amount of COVID-19 monoclonal antibody (mAb) treatment courses remain unused, says a new rapid expert consultation from... covid 19monoclonal antibodystrategiesallocatescarce https://immunopathol.com/Article/ipp-40568 Clinical signs, symptoms, and severity of COVID-19 in patients with rheumatic diseases during the... Introduction: Recent studies have shown that patients with rheumatic diseases are more likely to experience severe cases of COVID-19. Additionally, certain... clinical signscovid 19rheumatic diseasessymptomsseverity https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0266922 Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients | PLOS... Background Maintenance drugs are used to treat chronic conditions. Several classes of maintenance drugs have attracted attention because of their potential to... covid 19elderly patientseffectcommonmaintenance